inhal
saccharopolyspora
rectivirgula
caus
farmer
lung
diseas
classic
exampl
hypersensit
pneumon
hp
monocyt
chemoattract
increas
bronchoalveolar
lavag
fluid
mice
challeng
rectivirgula
rectivirgula
induc
secret
alveolar
macrophag
test
hypothesi
receptor
cc
chemokin
essenti
develop
experiment
hp
treat
mice
antibodi
use
mice
administr
chang
respons
intratrach
administ
rectivirgula
anim
respond
fashion
similar
wildtyp
anim
intratrach
administ
rectivirgula
determin
influenc
interact
vitro
transfer
rectivirgulacultur
spleen
cell
rectivirgulasensit
mice
recipi
later
challeng
recipi
intratrach
rectivirgula
examin
lung
histolog
bronchoalveolar
lavag
fluid
characterist
use
determin
whether
adopt
transfer
occur
found
cultur
cell
anim
fulli
capabl
adopt
transfer
conclud
interact
necessari
develop
pulmonari
inflamm
respons
intratrach
administ
rectivirgula
cell
abl
adopt
transfer
experiment
hp
j
lab
clin
med
abbrevi
anova
analysi
varianc
balf
bronchoalveolar
lavag
fluid
cc
chemokin
ehp
experiment
hypersensit
pneumon
fld
farmer
lung
diseas
hepa
higheffici
particul
air
hp
hypersensit
pneumon
hsd
honestli
signific
differ
il
interleukin
mcp
monocyt
chemoattract
protein
macrophag
inflammatori
sem
standard
error
mean
th
thelper
tnf
tumor
necrosi
factor
h
ypersensit
pneumon
group
lung
diseas
result
repeat
pulmonari
exposur
variou
organ
antigen
materi
uncertain
immunopathogenet
mechan
inhal
saccharopolyspora
rectivirgula
caus
fld
classic
exampl
hp
hp
character
neutrophilia
balf
within
hour
inhal
follow
balf
lymphocytosi
chemokin
caus
chemotaxi
lymphocyt
eg
present
balf
releas
alveolar
macrophag
patient
acut
hp
found
intratrach
exposur
mice
rectivirgula
induc
remark
increas
balf
preced
balf
neutrophilia
lymphocytosi
increas
macrophag
also
note
mark
increas
balf
lesser
extent
tnf
murin
macrophag
cell
line
alveolar
macrophag
produc
chemokin
list
stimul
rectivirgula
data
suggest
local
chemokin
product
respons
later
influx
cell
compart
assess
bronchoalveolar
lavag
macrophag
repres
possibl
sourc
substanc
chemokin
respons
mediat
interact
solubl
chemokin
protein
receptor
belong
superfamili
g
proteincoupl
receptor
eleven
differ
ccfamili
chemokin
receptor
character
major
receptor
bind
high
affin
addit
chemotaxi
chemokin
influenc
differenti
lymphocyt
cell
promot
cell
develop
model
ehp
appear
mediat
cell
hypothes
absenc
effect
would
decreas
express
ehp
therefor
test
hypothesi
interact
increas
develop
ehp
treat
mice
antibodi
use
mice
defici
major
receptor
anim
pair
background
gift
gari
huffnagl
univers
michigan
ann
arbor
mich
male
wildtyp
jackson
laboratori
bar
harbor
main
male
mice
hous
laminarflow
hood
hepafilt
air
veterinari
medic
unit
fulli
accredit
american
associ
accredit
laboratori
anim
care
antigen
rectivirgula
prepar
previous
describ
studi
design
primari
outcom
measur
extent
pulmonari
histolog
abnorm
also
measur
balf
cell
type
count
balf
cytokin
chemokin
measur
use
character
inflammatori
milieu
within
lung
measur
effect
administ
mg
polyclon
rabbit
phosphatebuff
salin
solut
intraperiton
ml
hour
hour
gg
intratrach
administ
rectivirgula
mice
anim
kill
hour
schedul
base
previou
work
demonstr
effect
vivo
treatment
antimcp
gener
polyclon
rabbit
immun
rabbit
murin
recombin
r
system
minneapoli
minn
multipl
intraderm
site
complet
freund
adjuv
serum
purifi
protein
column
assess
direct
effect
intratrach
administ
rectivirgula
wildtyp
mice
anesthet
mice
inject
lyophil
rectivirgula
suspend
steril
pyrogenfre
normal
salin
solut
trachea
mouth
mice
kill
day
cytokin
chemokin
level
day
histolog
studi
balf
cell
thereaft
time
chosen
cytokin
level
peak
hour
intratrach
administr
rectivirgula
histolog
chang
peak
hour
also
measur
abil
cultur
cell
sensit
wildtyp
mice
transfer
ehp
mice
strain
mice
immun
intratrach
inject
rectivirgula
kill
day
thereaft
spleen
cell
cultur
rectivirgula
gml
hour
cell
media
life
technolog
gaithersburg
pa
inject
recipi
challeng
day
thereaft
intratrach
administ
rectivirgula
kill
hour
thereaft
balf
balf
cell
obtain
mean
lavag
wash
ml
normal
salin
solut
supernat
first
combin
wash
frozen
later
chemokin
cytokin
analysi
cytokin
chemokin
cytokin
chemokin
measur
use
enzymelink
immunosorb
assay
unknown
sampl
compar
standard
curv
correspond
recombin
mous
cytokin
chemokin
histolog
studi
lung
inflat
formalin
cm
water
pressur
hour
embed
singl
paraffin
block
section
waq
cut
stain
hematoxylin
eosin
slide
evalu
without
knowledg
treatment
area
cover
eyepiec
grid
mm
magnif
magnif
judg
normal
abnorm
abnorm
field
one
increas
number
cell
interstitium
alveoli
averag
field
evalu
mous
area
coverslip
method
yield
reproduc
result
r
duplic
read
anim
data
analysi
analyz
balf
cellular
data
cytokin
chemokin
extent
histolog
chang
use
anova
tukey
conserv
hsd
procedur
post
hoc
test
consid
p
valu
less
signific
post
hoc
test
signific
multipl
anova
appli
effect
rabbit
prepar
could
block
least
ngml
crossreact
tnf
transform
growth
treatment
mice
chang
test
extent
pulmonari
histopatholog
find
respons
gg
intratrach
administ
rectivirgula
mean
sem
compar
anim
treat
equal
volum
phosphatebuff
salin
solut
chang
number
characterist
balf
cell
data
shown
anim
extent
histolog
abnorm
wildtyp
mice
depend
amount
rectivirgula
administ
type
anim
p
vs
wildtyp
fig
twoway
anova
note
increas
balf
cell
wildtyp
mice
administr
everi
dose
rectivirgula
tabl
total
number
macrophag
eosinophil
wildtyp
anim
found
small
differ
total
number
lymphocyt
wildtyp
multipl
anova
number
cell
macrophag
lymphocyt
neutrophil
eosinophil
relat
amount
rectivirgula
administ
found
differ
among
strain
p
multipl
anova
amount
rectivirgula
administ
relat
level
p
multipl
anova
note
differ
wildtyp
mice
regard
wildtyp
wildtyp
tabl
ii
increas
decreas
compar
wildtyp
mice
similar
result
report
other
adopt
transfer
ehp
wildtyp
anim
transfer
cultur
spleen
cell
confer
abil
respond
extens
pulmonari
histolog
abnorm
compar
anim
administ
medium
intratrach
challeng
rectivirgula
fig
wildtyp
mice
found
extens
infiltr
perivascular
peribronchiolar
area
mixtur
lymphocyt
macrophag
plasma
cell
fig
similar
find
aj
balbc
mice
found
minor
differ
regard
total
balf
cell
number
fig
increas
number
cell
wildtyp
anim
receiv
transfer
cell
compar
receiv
strain
exhibit
increas
number
lymphocyt
cell
recipi
compar
rpmi
recipi
anim
receiv
transfer
cell
increas
number
neutrophil
twoway
anova
factor
strain
treatment
rpmi
cell
demonstr
treatment
ie
rpmi
cell
relat
p
number
cell
neutrophil
differ
strain
total
number
lymphocyt
differ
strain
well
treatment
lymphocyt
wildtyp
anim
found
eosinophil
differ
group
found
increas
wildtyp
anim
receiv
cell
rpmi
peak
hour
fig
multipl
anova
p
also
found
increas
wildtyp
anim
receiv
cell
compar
anim
receiv
cell
fig
multipl
anova
p
analyz
cultur
supernat
determin
cytokinesecret
profil
inject
cell
found
supernat
anim
produc
less
wildtyp
anim
tabl
iii
detect
supernat
differ
strain
hp
character
appear
neutrophil
hour
day
lymphocyt
balf
mechan
balf
neutrophilia
lymphocytosi
may
includ
effect
chemokin
detect
balf
patient
hp
chemokin
famili
small
discret
chemotact
protein
divid
differ
group
depend
structur
cc
chemokin
anoth
amino
acid
first
conserv
cystein
preferenti
attract
monocyt
eosinophil
basophil
lymphocyt
known
je
mous
promin
member
ccchemokin
famili
appar
import
patholog
condit
associ
monocytemacrophag
infiltr
atherosclerosi
rheumatoid
arthriti
experiment
allerg
encephalomyel
idiopath
pulmonari
fibrosi
acut
respiratori
distress
syndrom
psoriasi
experiment
glomerulonephr
diabet
allograph
reject
produc
mani
differ
cell
type
type
ii
alveolar
cell
monocyt
endotheli
cell
macrophag
fibroblast
mast
cell
keratinocyt
smoothmuscl
cell
ligand
express
monocyt
activ
tcell
bcell
natur
killer
cell
fibroblast
mast
cell
famili
transmembranespan
receptor
affect
cell
way
interact
differ
gprotein
although
princip
agonist
agonist
includ
human
immunodefici
viru
tat
howev
mice
bind
summertyp
hp
common
caus
hp
japan
balf
concentr
show
correl
balf
lymphocyt
count
rat
immun
complexmedi
lung
injuri
increas
amount
balf
monocyt
chemotact
activ
could
neutral
antibodi
markedli
increas
express
alveolar
macrophag
messeng
rna
increas
vitro
secret
alveolar
macrophag
level
increas
bleomycin
treatment
rat
day
previous
demonstr
intratrach
administr
rectivirgula
agent
caus
fld
human
be
caus
appear
substanti
amount
balf
preced
later
increas
balf
neutrophil
mononuclear
cell
count
therefor
find
increas
rectivirgulainduc
balf
preced
influx
lymphocyt
suggest
respons
cellular
influx
balf
howev
mani
potenti
chemotact
factor
present
lung
subject
expos
agent
caus
hp
model
ehp
mice
complement
fragment
chemokin
therefor
clear
respons
balf
mononuclear
cell
influx
model
addit
chemotact
activ
influenc
differenti
antigenspecif
cell
promot
develop
cell
model
cell
sensit
mice
cultur
rectivirgula
extract
transfer
increas
sensit
intratrach
administ
rectivirgula
defin
extent
pulmonari
inflamm
cell
effect
transfer
characterist
cell
line
abl
transfer
ehp
test
hypothesi
enhanc
develop
ehp
first
approach
block
activ
vivo
use
antibodi
found
effect
pulmonari
histolog
balf
respons
use
schedul
other
demonstr
effect
use
neutral
antibodi
ablat
influenc
cytokin
chemokin
may
effect
result
dose
schedul
issu
addit
antibodi
caus
format
antigenantibodi
complex
induc
complement
mediat
tissu
injuri
mice
readili
avail
use
mice
determin
influenc
ehp
compar
wildtyp
anim
mice
exhibit
decreas
tissu
inflamm
confront
inflammatori
stimuli
infect
also
demonstr
reduc
delayedtyp
hypersensit
reaction
granuloma
format
suscept
infect
listeria
leishmania
central
nervou
system
coronaviru
cryptococcu
exhibit
decreas
macrophag
recruit
lung
infect
influenza
mice
also
exhibit
increas
airway
reactiv
sensit
aspergillu
resist
experiment
allerg
encephalomyel
gener
anim
exhibit
decreas
respons
reduc
product
cytokin
increas
product
therefor
compar
histolog
balf
respons
one
intratrach
inject
rectivirgulain
wildtyp
anim
found
anim
receiv
cultur
spleen
cell
sensit
mice
day
challeng
rectivirgula
wild
type
hematoxylin
eosin
stain
origin
magnif
note
extens
perivascular
peribronchiolar
alveolar
infiltr
mixtur
neutrophil
macrophag
lymphocyt
b
bronchiol
arrow
denot
perivascular
peribronchiolar
infiltr
b
hematoxylin
eosin
stain
origin
magnif
note
extens
perivascular
peribronchiolar
alveolar
infiltr
mixtur
neutrophil
macrophag
lymphocyt
b
bronchiol
v
vessel
arrow
denot
perivascular
peribronchiolar
infiltr
differ
regard
extent
characterist
pulmonari
histolog
abnorm
mice
compar
wild
type
anim
fig
degre
pulmonari
inflamm
reflect
balf
cell
characterist
relat
amount
rectivirgula
administ
mous
strain
minor
isol
differ
lymphocyt
count
tabl
amount
increas
balf
anim
tabl
ii
similar
observ
system
could
predict
detect
balf
anim
amount
balf
decreas
anim
find
decreas
number
macrophag
increas
number
neutrophil
eosinophil
balf
mice
compar
wildtyp
mice
tabl
report
previous
intraperiton
inject
thioglycol
may
relat
differ
stimuli
thioglycol
vs
rectivirgula
anatom
site
peritoneum
vs
lung
time
vs
hour
moor
colleagu
likewis
report
differ
pulmonari
inflamm
wildtyp
mice
week
intratrach
inject
fluorescein
isothiocyan
despit
later
dif
ferenc
lung
fibrosi
day
bleas
found
small
differ
balf
cell
intratrach
challeng
aspergillu
traynor
found
differ
total
cell
number
lung
cryptococcusinfect
nimal
week
infect
therefor
like
lack
differ
pulmonari
inflamm
observ
wildtyp
anim
relat
mostli
anatom
site
pulmonari
inflamm
often
rel
normal
mice
oppos
peritoneum
find
evid
switch
immun
respons
profil
mice
describ
traynor
colleagu
experiment
cryptococc
infect
sato
leishmaniainfect
mice
reason
differ
like
relat
time
day
model
vs
week
cryptococc
model
week
leishmania
model
perhap
natur
pulmonari
challeng
nonrepl
bacteria
vs
replic
fungu
howev
find
decreas
secret
cultur
cell
supernat
tabl
iii
similar
report
sato
find
increas
concentr
inflammatori
cytokin
tumor
necrosi
factor
balf
tabl
ii
either
mous
strain
probabl
result
time
elaps
sinc
intratrach
challeng
rectivirgula
hour
previous
demonstr
hour
rectivirgula
exposur
cytokin
return
baselin
level
next
cultur
cell
wildtyp
mice
sensit
rectivirgula
cultur
cell
anim
secret
less
cell
wildtyp
mice
tabl
iii
therefor
resembl
cell
although
amount
decreas
absent
cultur
supernat
similar
result
report
other
presenc
cultur
supernat
anim
may
caus
induc
secret
present
supernat
concentr
cell
cultur
wildtyp
anim
cultur
cell
wildtyp
mice
equal
compet
abil
adopt
transfer
ehp
defin
increas
extent
pulmonari
histolog
chang
intratrach
challeng
rectivirgula
fig
similar
find
model
murin
asthma
mycobacteri
infect
employ
anim
natur
pulmonari
inflammatori
respons
differ
recipi
compar
wildtyp
recipi
fig
find
differ
balf
mice
control
anim
fig
find
differ
regard
pulmonari
histolog
balf
cellular
respons
mice
fig
like
cytokin
necessari
express
pulmonari
inflamm
adoptivetransf
model
lack
effect
absenc
interact
develop
cell
capabl
transfer
ehp
suggest
addit
pathway
model
experiment
hypersensit
pneumon
result
recruit
inflammatori
cell
lung
exposur
rectivirgula
like
consequ
redund
natur
chemokinechemokin
receptor
system
multipl
chemokin
interact
mani
differ
receptor
perhap
natur
antigen
use
rectivirgula
activ
complement
caus
secret
inflammatori
cytokin
act
adjuv
addit
time
exposur
may
import
overexpress
sensit
mice
either
ppd
schistosoma
antigen
markedli
alter
extent
granulomat
respons
wherea
overexpress
sensit
chang
granulomat
respons
summari
could
demonstr
essenti
role
receptor
model
ehp
despit
consider
evid
link
ehp
chemokin
failur
like
reflect
complex
natur
interact
lung
antigen
materi
caus
hp
human
be
like
exist
multipl
redund
pathway
lung
injuri
hp
impli
measur
aim
singl
mechan
would
expect
decreas
pulmonari
inflammatori
respons
diseas
extent
hp
resembl
inflammatori
lung
diseas
eg
idiopath
pulmonari
fibrosi
cystic
fibrosi
adult
respiratori
distress
syndrom
similar
lack
singl
domin
mechan
injuri
would
predict
necess
multipl
interact
reduc
lung
damag
acknowledg
excel
technic
assist
susan
baca
maintain
coloni
kathi
kilpatrick
perform
polymeras
chain
reaction
assay
